VEGFA levels are significantly elevated in the proliferative phase of infantile hemangiomas, and gradually decrease in the regression phase, which is highly correlated with the development of infantile hemangiomas.36 Also, it is well known that the VEGFA‐mediated VEGFA/VEGFR pathway is an important signaling pathway involved in the development of hemangiomas, and also VEGFA interacts with HIF‐1α to regulate angiogenesis.37 In our research, bioinformatics analysis revealed that VEGFA is a miR‐382‐5p target. The gene discussed is VEGFA; the disease is hemangioma.